Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes

There is a current imperative to unravel the hierarchy of molecular pathways that drive the transition of early to established disease in rheumatoid arthritis (RA). Herein, we report a comprehensive RNA sequencing analysis of the molecular pathways that drive early RA progression in the disease tiss...

Ամբողջական նկարագրություն

Մատենագիտական մանրամասներ
Հիմնական հեղինակներ: Lewis, MJ, Barnes, MR, Blighe, K, Goldmann, K, Rana, S, Hackney, J, Ramamoorthi, N, John, CR, Watson, D, Kummerfeld, SK, Hands, R, Riahi, S, Rocher-Ros, V, Rivellese, F, Humby, F, Kelly, S, Bombardieri, M, Ng, N, Dicicco, M, Van Der Heijde, D, Landewe, R, Van Der Helm-Van Mil, A, Cauli, A, McInnes, IB, Buckley, CD, Choy, E, Taylor, PC, Townsend, MJ, Pitzalis, C
Ձևաչափ: Journal article
Հրապարակվել է: Cell Press 2019
Նկարագրություն
Ամփոփում:There is a current imperative to unravel the hierarchy of molecular pathways that drive the transition of early to established disease in rheumatoid arthritis (RA). Herein, we report a comprehensive RNA sequencing analysis of the molecular pathways that drive early RA progression in the disease tissue (synovium), comparing matched peripheral blood RNA-seq in a large cohort of early treatment-naive patients, namely, the Pathobiology of Early Arthritis Cohort (PEAC). We developed a data exploration website (https://peac.hpc.qmul.ac.uk/) to dissect gene signatures across synovial and blood compartments, integrated with deep phenotypic profiling. We identified transcriptional subgroups in synovium linked to three distinct pathotypes: fibroblastic pauci-immune pathotype, macrophage-rich diffuse-myeloid pathotype, and a lympho-myeloid pathotype characterized by infiltration of lymphocytes and myeloid cells. This is suggestive of divergent pathogenic pathways or activation disease states. Pro-myeloid inflammatory synovial gene signatures correlated with clinical response to initial drug therapy, whereas plasma cell genes identified a poor prognosis subgroup with progressive structural damage.